about
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesHighly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentProposal of a novel system for the staging of thymic epithelial tumors.Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type.Pulmonary resections: cytostructural effects of different-wavelength lasers versus electrocautery.Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.SYT-SSX fusion genes and prognosis in synovial sarcoma.Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?Grading lung neuroendocrine tumors: Controversies in search of a solution.Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells.ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material ApproachLung metastases of adenoid cystic carcinoma mimicking broncho alveolar carcinoma growth patternExperience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantationReduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung CancerResection versus transplantation for liver metastases from neuroendocrine tumors
P50
Q24645724-B8690F5E-E8F9-4C79-906F-CBDD422A46AEQ24656967-E0DDFBD9-6456-4DA4-8AF4-B9C5B0E73FE9Q33991620-C2E4B142-B5DD-4180-9597-6804001CC1D5Q34157789-B41DB37D-29AB-4BF1-B22A-67F9D22233BCQ34229282-68262FEC-463D-4BCB-AC7E-E8C5B03DC7F9Q34932910-19A10EAB-9C8C-43C8-A17E-FC7028AC5C33Q36623165-7086AC12-E278-495B-BB95-15A4A47E8521Q38382493-7A80EED1-5895-469D-9D72-6B546AE0B121Q38631604-DE3141D5-D774-472D-9804-19E43FC2771BQ38954551-1C6A8482-B330-4D01-AB87-0C61F1860F00Q39977561-09E80223-79FE-46CB-AB43-A9483D2C9188Q40395607-C1D5268F-7078-412F-82AA-74AF6C974EE9Q40812047-771504C4-4705-42EB-A83E-C3A5AE467C11Q40954652-7CA2CBD8-9384-491E-94DF-E381E9698C71Q41442485-1ED1BA76-4842-4466-A6A7-322C9C8F242FQ45276482-B5D55BA4-19AC-407F-B9A8-F43D08F09BCEQ46190550-F2871915-B92D-477B-9A94-13A16C919616Q46437964-17639451-CCB0-4837-9C81-1324E6120CBBQ47653473-09B7D498-EA70-4854-A627-D43BD3E9023AQ51181963-6F153905-E03C-4C2C-991A-7522CE9127B4Q52914937-91D3883F-B615-43B7-9C99-DE2600EA0316Q56779202-86831243-F3B5-44AD-AB1C-FE3C83544025Q57763025-7254F895-78F3-4729-88BE-8EA9DEBAA2F8Q57763471-354AD103-0D58-49A4-924C-B30C09F11992Q59287273-E824DBA7-888D-40C1-932A-8573B8D9EEA2Q61623028-BE99021D-2750-4B24-9101-61EFFD913957
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandra Fabbri
@ast
Alessandra Fabbri
@en
Alessandra Fabbri
@es
Alessandra Fabbri
@nl
Alessandra Fabbri
@sl
type
label
Alessandra Fabbri
@ast
Alessandra Fabbri
@en
Alessandra Fabbri
@es
Alessandra Fabbri
@nl
Alessandra Fabbri
@sl
prefLabel
Alessandra Fabbri
@ast
Alessandra Fabbri
@en
Alessandra Fabbri
@es
Alessandra Fabbri
@nl
Alessandra Fabbri
@sl
P1053
D-8636-2017
P106
P1153
7102285964
P21
P31
P3829
P496
0000-0002-1589-1569